GXGang Xu

Gang Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gang Xu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Da-Qiang Sun

    Department of Thoracic Surgery Tianjin Chest Hospital Tianjin China

    1 shared publication
  • Daxing Liu

    Department of Biomedical Engineering, The City College of New York, 160 Convent Avenue, New York, NY 10031, USA

    1 shared publication
  • Gui-You Liang

    Department of Thoracic and Cardiovascular Surgery, Affiliated Hospital of Zunyi Medical College, Guizhou 563003, P.R. China

    1 shared publication
  • Hui Ming

    Oncology Department, The 960th Hospital of the PLA, No. 20 Zhanbei Road, Zibo, 255300 Shandong China

    1 shared publication
  • J-B. Zhang

    PLA 148 Hosp, Dept Oncol, Zibo, Peoples R China

    1 shared publication
  • Jinbiao Zhang

    Oncology Department, The 960th Hospital of the PLA, No. 20 Zhanbei Road, Zibo, 255300 Shandong China

    1 shared publication

Latest Publications

  • Does hyperuricemia correlate with intervertebral disc degeneration?

    by Yvang Chang, Ming Yang, Yu Zhang, Gang Xu, Zhonghai Li


  • Open Access

    LBX2-AS1 up-regulated by NFIC boosts cell proliferation, migration and invasion in gastric cancer through targeting miR-491-5p/ZNF703

    by Gang Xu, Yan Zhang, Na Li, Yanling Wu, Jinbiao Zhang, Rui Xu, Hui Ming

    Background: The crucial role of long non-coding RNAs (lncRNAs) has been certified in human cancers. The lncRNAs with abnormal expressions could act as tumor inhibitors or oncogenes in the advancement of tumors. LBX2-AS1 was once reported to accelerate esophageal squamous cell carcinoma. Nonetheless, its function in gastric cancer (GC) remained a riddle. Methods: RT-qPCR was used to examine the expression of NFIC/LBX2-AS1/miR-491-5p/ZNF703 in GC cell lines. The functions of LBX2-AS1 in GC were appraised by colony formation, EdU, flow cytometry analysis, transwell and wound healing assays. Luciferase reporter, ChIP and RNA pull down assays were utilized to evaluate the interactions among genes. Results: LBX2-AS1 was up-regulated in GC cell lines. Knockdown of LBX2-AS1 repressed the proliferative, migratory, and invasive abilities of GC cells. Moreover, LBX2-AS1 was transcriptionally activated by NFIC. And LBX2-AS1 could bind with miR-491-5p. Besides, miR-491-5p depletion or ZNF703 upregulation could counteract the repressing effects of LBX2-AS1 silence on GC progression. Conclusion: In a word, LBX2-AS1 up-regulated by NFIC promoted GC progression via targeting miR-491-5p/ZNF703, implying LBX2-AS1 was an underlying treatment target for GC patients.


  • Open Access

    MicroRNA-383-5p inhibits the progression of gastric carcinoma via targeting HDAC9 expression

    by Gang Xu, Na Li, Yan Zhang, Jinbiao Zhang, Rui Xu, Yanling Wu

    MicroRNAs (miRNAs), as post-transcriptional regulators, have been reported to be involved in the initiation and progression of various types of cancer, including gastric cancer (GC). The present study aimed to investigate the role of miR-383-5p in gastric carcinogenesis. Cell viability was analyzed using CCK-8 kit. Annexin V-fluorescein isothiocyanate/propidium iodide double staining was used to evaluate cell apoptosis. The expression levels of miR-383-5p and histone deacetylase 9 (HDAC9) mRNA in GC tissues and cell lines were analyzed using RT-qPCR. The protein expression of HDAC9 was detected by western blotting. We found that HDAC9 was up-regulated and miR-383-5p was down-regulated in GC tissues and cell lines. High HDAC9 expression or low miR-383-5p expression was closely related to poor prognosis and metastasis in GC patients. HDAC9 knockout or miR-383-5p mimics led to growth inhibition and increased apoptosis in AGS and SGC-7901 cells. More importantly, we validated that miR-383-5p as a post-transcriptional regulator inhibited HDAC9 expression and was inversely correlated with HDAC9 expression in GC tissues. miR-383-5p had the opposite effects to HDAC9 in gastric carcinogenesis. miR-383-5p played an important role in gastric carcinogenesis, and it is one of the important mechanisms to regulate oncogenic HDAC9 in GC, which might be helpful in the development of novel therapeutic strategies for the treatment of GC.


    • 1 May 2018
      • Vol. 22  (9) , 2631-2637

    LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer cells

    by G. Xu, Y. Zhang, N. Li, J-B. Zhang, R. Xu

    OBJECTIVE: We aimed at Investigating the effects of long non-coding RNA (IncRNA) CCHE1 on proliferation and apoptosis of gastric cancer cells. MATERIALS AND METHODS: qRT-PCR method was used to detect IncRNA CCHE1 in cancer cell lines. Cells with relative expression were selected to change the expression by transfecting with corresponding lentiviral vector, and nonsense transfection group and blank control group were also constructed; cell counting kit-8 (CCK-8) method was used to assess cell proliferation activity; colony formation assay was used to evaluate the rate of cell cloning; flow cytometry assay was used to determine the apoptosis rate and cell cycle. Western blot was utilized to detect the expressions of Bax and Bcl-2. RESULTS: Expression of IncRNA CCHE1 in the tumor cell lines was increased (p<0.05). Up-regulated IncRNA CCHE1 increased proliferative activity and colony formation capacity. However, down-regulated IncRNA CCHE1 decreased proliferative activity and colony formation capacity. Bcl-2 protein expression increased, but Bax protein expression decreased in IncRNA CCHE1 upregulation group (p<0.05); the effect was reversed in IncRNA CCHE1 down-regulation group (p<0.05). CONCLUSIONS: IncRNA CCHE1 may promote the proliferation of gastric cancer cells and inhibit cell apoptosis.


  • Open Access

    Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivo

    by Yu-Guang Shen, Wen Feng, Yi-Jun Xu, Na-Na Jiao, Da-Qiang Sun, Wen-Dong Qu, Quan Tang, Wei Xiong, Yang Tang, Yu Xia, et al.

    Esophageal carcinoma is one of the most common malignancies in China. Previous studies reported that matrix metalloproteinases (MMPs) have important roles in the progression and invasion of numerous types of solid tumors. Among the MMPs, MMP-2 has been closely associated with tumor growth and invasion. In the present study, a short hairpin RNA (shRNA) lentiviral expression vector targeting the MMP-2 gene was constructed in order to observe the inhibitory effect of MMP-2 gene silencing on the growth of the KYSE150 esophageal carcinoma cell line in vivo. Three small hairpin RNA sequences targeting MMP-2 were designed and cloned into lentiviral vectors. Following transfection of the lentiviral vectors into KTSE150 cells, MMP-2 mRNA and protein expression levels were examined by reverse transcription-quantitative polymerase chain reaction and western blotting, and the growth rate of cells was analyzed by MTT assays. Subsequently, tumor growth was assessed in nude mice. Lentivirus-mediated RNA interference effectively inhibited the expression of MMP-2 mRNA and protein in KYSE150 esophageal carcinoma cells, and suppressed the growth of esophageal carcinoma cells in vivo. The results of the present study suggested that lentivirus-mediated gene therapy targeting MMP-2 may be an attractive strategy for the treatment of esophageal carcinoma and justifies the performance of further studies on the application of lentivirus vectors to cancer gene therapy.